Table of Contents
Introduction
Continuous glucose monitoring (CGM) is a crucial method for managing blood sugar levels in diabetic patients. Currently, the most common approach to CGM involves invasive methods such as using needles and transmitters. However, medical diagnostic company Know Labs is set to revolutionize the field with its Generation (Gen) 1 device, which is aimed to be the world’s first commercially available non-invasive glucose monitor. This article will explore the key features of the Gen 1 device and its potential impact on the market.
The Generation (Gen) 1 Device Prototype
The Gen 1 device prototype developed by Know Labs utilizes radio waves and machine learning algorithms to measure blood sugar levels non-invasively through the skin. By leveraging the company’s Bio-RFID technology, the device can consistently and accurately capture molecular signatures of glucose levels. This groundbreaking technology sets Know Labs apart in a market that lacks commercially available non-invasive glucose monitors.
The Science behind the Gen 1 Device
The Gen 1 device operates by sending radio waves through the skin to capture molecular signatures associated with blood sugar levels. These readings are then processed by sophisticated algorithms, which transform them into glucose-level information. The technology’s accuracy was further enhanced by the recent addition of a light gradient boosting machine learning model to the algorithm.
Advancements in Algorithm and Data Collection
Know Labs continues to refine its algorithms through data collection during clinical research studies. The portable nature of the Gen 1 device allows for data collection in various participant populations and settings. The company aims to test the device across diverse scenarios to ensure its reliability and accuracy. In 2023, Know Labs plans to focus on external validation of the technology, further solidifying its position as a game-changer in non-invasive glucose monitoring.
Smartphone Integration and Future Developments
The Gen 1 device is designed to connect with a smartphone app, allowing users to conveniently view glucose parameters and information. Know Labs has plans to develop a wearable wristband that incorporates the same technology, providing users with continuous monitoring without the need for constant smartphone connectivity. This future development shows the company’s commitment to expanding its product line and catering to the needs of its users.
The Growing Market for Non-Invasive Glucose Monitoring
Currently, the market for blood sugar management devices, including CGMs, is projected to reach $1.6 billion by 2030. Additionally, the sensor technology market is expected to reach $5 billion in the same year. The introduction of non-invasive monitoring devices like the Gen 1 device represents a new frontier in the field of on-demand glucose monitoring. By eliminating the need for needles and invasive transmitters, these devices offer a more comfortable and convenient option for diabetic patients.
Competitors in the Race for Non-Invasive Glucose Monitoring
While Know Labs has taken the lead in developing the Gen 1 device, other companies are also striving to bring non-invasive glucose monitoring technology to the market. Afon’s Blood Glucose Sensor is one such competitor, aiming to offer a non-invasive solution for blood sugar monitoring. Additionally, there are rumors of a secretive sensing technology being implemented into watches by a well-known tech company. The race to cross the regulatory finish line has intensified, as companies recognize the potential of non-invasive glucose monitoring.
Conclusion
Know Labs’ Generation (Gen) 1 device is poised to revolutionize the way blood sugar levels are monitored and managed. By leveraging radio waves and machine learning algorithms, the device offers a non-invasive and accurate method of glucose monitoring. With further refinement of algorithms and external validation, the Gen 1 device has promising potential to become the go-to solution for continuous glucose monitoring. By providing diabetic patients with a more comfortable and convenient option, Know Labs is leading the charge in non-invasive glucose monitoring technology.
